Kindstar Globalgene Technology (HKSE:09960) FCF Margin % : -13.42% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kindstar Globalgene Technology's Free Cash Flow for the six months ended in Jun. 2023 was HK$-72 Mil. Kindstar Globalgene Technology's Revenue for the six months ended in Jun. 2023 was HK$539 Mil. Therefore, Kindstar Globalgene Technology's FCF Margin % for the quarter that ended in Jun. 2023 was -13.42%.

As of today, Kindstar Globalgene Technology's current FCF Yield % is -7.05%.

The historical rank and industry rank for Kindstar Globalgene Technology's FCF Margin % or its related term are showing as below:

HKSE:09960' s FCF Margin % Range Over the Past 10 Years
Min: -23.66 Med: -0.93 Max: 6.93
Current: -10.17

During the past 6 years, the highest FCF Margin % of Kindstar Globalgene Technology was 6.93%. The lowest was -23.66%. And the median was -0.93%.

HKSE:09960's FCF Margin % is ranked better than
50.45% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51 vs HKSE:09960: -10.17

Kindstar Globalgene Technology FCF Margin % Historical Data

The historical data trend for Kindstar Globalgene Technology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology FCF Margin % Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

6.93

5.24

-23.66

-7.42

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-43.88	-10.82	-4.34	-13.42	-

Competitive Comparison of Kindstar Globalgene Technology's FCF Margin %

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's FCF Margin % falls into.

Kindstar Globalgene Technology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kindstar Globalgene Technology's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-114.912	/	1548.427
	=	-7.42 %

Kindstar Globalgene Technology's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-72.345	/	538.971
	=	-13.42 %

Kindstar Globalgene Technology FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines